145 related articles for article (PubMed ID: 19362835)
21. Synthesis and preliminary bioevaluation of novel E-ring modified acetal analog of camptothecin as cytotoxic agents.
Zhu L; Zhuang C; Lei N; Guo Z; Sheng C; Dong G; Wang S; Zhang Y; Yao J; Miao Z; Zhang W
Eur J Med Chem; 2012 Oct; 56():1-9. PubMed ID: 23084702
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, characterization, and preliminary in vivo tests of new poly(ethylene glycol) conjugates of the antitumor agent 10-amino-7-ethylcamptothecin.
Guiotto A; Canevari M; Orsolini P; Lavanchy O; Deuschel C; Kaneda N; Kurita A; Matsuzaki T; Yaegashi T; Sawada S; Veronese FM
J Med Chem; 2004 Feb; 47(5):1280-9. PubMed ID: 14971908
[TBL] [Abstract][Full Text] [Related]
23. Complete regression of xenografted human carcinomas by camptothecin analogue-carboxymethyl dextran conjugate (T-0128).
Okuno S; Harada M; Yano T; Yano S; Kiuchi S; Tsuda N; Sakamura Y; Imai J; Kawaguchi T; Tsujihara K
Cancer Res; 2000 Jun; 60(11):2988-95. PubMed ID: 10850447
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of a new class of camptothecin derivatives, the long-chain fatty acid esters of 10-hydroxycamptothecin, as a potent prodrug candidate, and their in vitro metabolic conversion by carboxylesterases.
Takayama H; Watanabe A; Hosokawa M; Chiba K; Satoh T; Aimi N
Bioorg Med Chem Lett; 1998 Mar; 8(5):415-8. PubMed ID: 9871589
[TBL] [Abstract][Full Text] [Related]
25. Novel 7-oxyiminomethyl derivatives of camptothecin with potent in vitro and in vivo antitumor activity.
Dallavalle S; Ferrari A; Biasotti B; Merlini L; Penco S; Gallo G; Marzi M; Tinti MO; Martinelli R; Pisano C; Carminati P; Carenini N; Beretta G; Perego P; De Cesare M; Pratesi G; Zunino F
J Med Chem; 2001 Sep; 44(20):3264-74. PubMed ID: 11563925
[TBL] [Abstract][Full Text] [Related]
26. A new strategy to improve the metabolic stability of lactone: discovery of (20S,21S)-21-fluorocamptothecins as novel, hydrolytically stable topoisomerase I inhibitors.
Miao Z; Zhu L; Dong G; Zhuang C; Wu Y; Wang S; Guo Z; Liu Y; Wu S; Zhu S; Fang K; Yao J; Li J; Sheng C; Zhang W
J Med Chem; 2013 Oct; 56(20):7902-10. PubMed ID: 24069881
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and antitumor activity of novel water soluble derivatives of camptothecin as specific inhibitors of topoisomerase I.
Luzzio MJ; Besterman JM; Emerson DL; Evans MG; Lackey K; Leitner PL; McIntyre G; Morton B; Myers PL; Peel M
J Med Chem; 1995 Feb; 38(3):395-401. PubMed ID: 7853331
[TBL] [Abstract][Full Text] [Related]
28. 10-Boronic acid substituted camptothecin as prodrug of SN-38.
Wang L; Xie S; Ma L; Chen Y; Lu W
Eur J Med Chem; 2016 Jun; 116():84-89. PubMed ID: 27060760
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of 14-azacamptothecin, a water-soluble topoisomerase I poison.
Rahier NJ; Cheng K; Gao R; Eisenhauer BM; Hecht SM
Org Lett; 2005 Mar; 7(5):835-7. PubMed ID: 15727453
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and in vivo antitumor activity of poly(l-glutamic acid) conjugates of 20S-camptothecin.
Bhatt R; de Vries P; Tulinsky J; Bellamy G; Baker B; Singer JW; Klein P
J Med Chem; 2003 Jan; 46(1):190-3. PubMed ID: 12502373
[TBL] [Abstract][Full Text] [Related]
31. Alkyl esters of camptothecin and 9-nitrocamptothecin: synthesis, in vitro pharmacokinetics, toxicity, and antitumor activity.
Cao Z; Harris N; Kozielski A; Vardeman D; Stehlin JS; Giovanella B
J Med Chem; 1998 Jan; 41(1):31-7. PubMed ID: 9438019
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Nitrobenzyl Derivatives of Camptothecin as Anti-Cancer Agents and Potential Hypoxia Targeting Prodrugs.
Liang D; Wu X; Hasinoff BB; Herbert DE; Tranmer GK
Molecules; 2018 Aug; 23(8):. PubMed ID: 30111719
[TBL] [Abstract][Full Text] [Related]
33. Antitumor potential of a novel camptothecin derivative, ZBH-ZM-06.
Wu D; Zhao DW; Li YQ; Shi WG; Yin QL; Tu ZK; Yu YY; Zhong BH; Yu H; Bao WG
Oncol Rep; 2018 Feb; 39(2):871-879. PubMed ID: 29251321
[TBL] [Abstract][Full Text] [Related]
34. Activation of a camptothecin prodrug by specific carboxylesterases as predicted by quantitative structure-activity relationship and molecular docking studies.
Yoon KJ; Krull EJ; Morton CL; Bornmann WG; Lee RE; Potter PM; Danks MK
Mol Cancer Ther; 2003 Nov; 2(11):1171-81. PubMed ID: 14617791
[TBL] [Abstract][Full Text] [Related]
35. Sustained delivery of a camptothecin prodrug - CZ48 by nanosuspensions with improved pharmacokinetics and enhanced anticancer activity.
Dong D; Hsiao CH; Giovanella BC; Wang Y; Chow DS; Li Z
Int J Nanomedicine; 2019; 14():3799-3817. PubMed ID: 31213802
[No Abstract] [Full Text] [Related]
36. Development of albumin-binding camptothecin prodrugs using a Peptide positional scanning library.
Schmid B; Warnecke A; Fichtner I; Jung M; Kratz F
Bioconjug Chem; 2007; 18(6):1786-99. PubMed ID: 17915955
[TBL] [Abstract][Full Text] [Related]
37. PSMA-Oriented Target Delivery of Novel Anticancer Prodrugs: Design, Synthesis, and Biological Evaluations of Oligopeptide-Camptothecin Conjugates.
Xu B; Zhou F; Yan MM; Cai DS; Guo WB; Yang YQ; Jia XH; Zhang WX; Li T; Ma T; Wang PL; Lei HM
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347770
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, topoisomerase I inhibitory activity, and in vivo evaluation of 11-azacamptothecin analogs.
Uehling DE; Nanthakumar SS; Croom D; Emerson DL; Leitner PP; Luzzio MJ; McIntyre G; Morton B; Profeta S; Sisco J
J Med Chem; 1995 Mar; 38(7):1106-18. PubMed ID: 7707314
[TBL] [Abstract][Full Text] [Related]
39. Development and pharmacological evaluation of a PEG based nanoparticulate camptothecin analog for oral administration.
Nekkanti V; Venkateswarlu V; Ansari KA; Pillai R
Curr Drug Deliv; 2011 Nov; 8(6):661-6. PubMed ID: 22313161
[TBL] [Abstract][Full Text] [Related]
40. Novel prodrugs of SN38 using multiarm poly(ethylene glycol) linkers.
Zhao H; Rubio B; Sapra P; Wu D; Reddy P; Sai P; Martinez A; Gao Y; Lozanguiez Y; Longley C; Greenberger LM; Horak ID
Bioconjug Chem; 2008 Apr; 19(4):849-59. PubMed ID: 18370417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
